Home > Income Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Consolidated Net Profit

    Back to Income Statement
PIRAMAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹91 Cr₹18 Cr₹-186 Cr₹376 Cr₹835 Cr

What is the latest Consolidated Net Profit of PIRAMAL PHARMA ?

The latest Consolidated Net Profit ratio of PIRAMAL PHARMA is ₹91 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹91 Cr
Mar2024₹18 Cr
Mar2023₹-186 Cr
Mar2022₹376 Cr
Mar2021₹835 Cr

How is Consolidated Net Profit of PIRAMAL PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹91 Cr
411.39
Mar2024 ₹18 Cr
Positive
Mar2023 ₹-186 Cr
Negative
Mar2022 ₹376 Cr
-54.98
Mar2021 ₹835 Cr -

Compare Consolidated Net Profit of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹21,240.6 Cr -5% 17.5% -24.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹436,859.0 Cr 5.2% 3.8% -1.8% Stock Analytics
DIVIS LABORATORIES ₹176,618.0 Cr 2.2% 11.3% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,718.0 Cr 0.8% 0.7% 25.7% Stock Analytics
CIPLA ₹107,722.0 Cr 1.3% 9.1% -15.7% Stock Analytics
DR REDDYS LABORATORIES ₹106,081.0 Cr -3.5% 2.7% 10.3% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

-5%

17.5%

-24.7%

SENSEX

-0.4%

7.1%

-4%


You may also like the below Video Courses